These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7983502)

  • 1. Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
    Olliaro P; Dautzenberg B
    J Chemother; 1994 Jun; 6(3):189-96. PubMed ID: 7983502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
    Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
    J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
    Sullam PM; Gordin FM; Wynne BA
    Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
    Reddy MV; Srinivasan S; Gangadharam PR
    Tuber Lung Dis; 1994 Jun; 75(3):208-12. PubMed ID: 7919314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
    Fournier S; Burguière AM; Flahault A; Vincent V; Treilhou MP; Eliaszewicz M
    Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):16-22. PubMed ID: 10192709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifabutin in the treatment of Mycobacterium avium complex infection: experience in Europe.
    Dautzenberg B
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S33-6. PubMed ID: 8785254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
    Agins BD; Berman DS; Spicehandler D; el-Sadr W; Simberkoff MS; Rahal JJ
    J Infect Dis; 1989 Apr; 159(4):784-7. PubMed ID: 2926169
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
    Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
    AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
    Dautzenberg B; Olliaro P; Ruf B; Esposito R; Opravil M; Hoy JF; Rozenbaum W; Carosi GP; Micoud M; L'Age M; Pirotta N; Sassella D
    Clin Infect Dis; 1996 Apr; 22(4):705-8. PubMed ID: 8729209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
    Kemper CA; Havlir D; Haghighat D; Dubé M; Bartok AE; Sison JP; Yao Y; Yangco B; Leedom JM; Tilles JG
    J Infect Dis; 1994 Jul; 170(1):157-64. PubMed ID: 8014492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
    Saito H; Sato K
    Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
    Benson CA; Williams PL; Currier JS; Holland F; Mahon LF; MacGregor RR; Inderlied CB; Flexner C; Neidig J; Chaisson R; Notario GF; Hafner R;
    Clin Infect Dis; 2003 Nov; 37(9):1234-43. PubMed ID: 14557969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.